Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment

BACKGROUND/AIMS: Data on treatment efficacy and safety of glecaprevir/pibrentasvir (GLE/PIB) for chronic hepatitis C virus (HCV) infection in Asian patients with severe renal impairment are limited. This study aimed to study the treatment and side effects of GLE/PIB in these patients infected with n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Desmond Y. H., Liu, Kevin S. H., Hsu, Yu-Chun, Wong, Grace L. H., Tsai, Ming-Chang, Chen, Chien-Hung, Hsu, Ching-Sheng, Hui, Yee Tak, Li, Michael K. K., Liu, Chen-Hua, Kan, Yee-Man, Yu, Ming-Lung, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641551/
https://www.ncbi.nlm.nih.gov/pubmed/32854457
http://dx.doi.org/10.3350/cmh.2020.0058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641551/
https://www.ncbi.nlm.nih.gov/pubmed/32854457
http://dx.doi.org/10.3350/cmh.2020.0058

Ejemplares similares